After Blood Clot Reports, Some Countries Stop Using the Oxford/AstraZeneca COVID-19 Vaccine
The European Medicines Agency (EMA) held an emergency meeting on Mar. 18, 2021 after many European countries suspended use of the Oxford/AstraZeneca experimental COVID-19 vaccine due to reports of severe side effects including blood clots, low platelet counts and death.1 The EMA conducted a preliminary investigation into potential serious side effects and pronounced the vaccine […]
J&J to Test COVID-19 Vaccine on Babies, Pregnant Women and the Immunocompromised
Pharmaceutical and medical device giant Johnson & Johnson, Inc. (J&J) announced on Feb. 28, 2021 plans to test its experimental Ad26.COV2.S vaccine for COVID-19 on infant children (including newborns), pregnant women and people with compromised immune systems. J&J did not include infants, pregnant women or the immunocompromised in the U.S. population in clinical trials on […]
AstraZeneca’s COVID-19 Vaccine Not Recommended for People Over 65 in Germany
Health officials in Germany have cautioned that the AstraZeneca/Oxford University COVID-19 vaccine (AZD1222) should not be given to people over the age of 65. Germany’s disease control agency, the Robert Koch Institute, only recommends the shot for people between the ages of 18-64 after concluding that there is not enough data available to determine whether the […]
Pfizer/BioNTech’s COVID-19 Vaccine Approved for Pregnant Women in Israel
Story Highlights The World Health Organization issued a Jan. 26, 2021 statement recommending that pregnant women should not be vaccinated with Moderna’s COVID-19 vaccine, approved for use under emergency authorization, citing a lack of data in pregnancy. Previously, most countries were in agreement with that opinion, but Israel is now recommending that pregnant women should […]
We Need More Details and Raw Data on Pfizer and Moderna COVID-19 Vaccines
On Nov. 26, 2020, when I raised questions1 about the results of Pfizer’s and Moderna’s COVID-19 vaccine trials, all that was in the public domain were the study protocols2 and a few press releases.3 Now, two journal publications4 and around 400 pages of summary data are available in the form of multiple reports presented by and to the U.S. Food and Drug […]
No Evidence COVID-19 Vaccines Will Block Spread of Coronavirus
On Nov. 9, 2020, Pfizer, Inc. announced that the experimental messenger RNA (mRNA) BNT162b2 vaccine for COVID-19 it developed in partnership with Germany’s BioNTech SE had an efficacy rate of 90 percent, based on the results of human clinical trials on the vaccine.1 2 3 This news was followed up a week later with an […]